drugset / Trial / NCT03557294
Varenicline OTC Trial on Efficacy and Safety
Phase 4
Completed
313 enrolled
Arizona State University
Los Angeles Clinical Trials · collabNational Institute on Drug Abuse (NIDA) · collabPfizer · collabUniversity of Nevada, Reno · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary goal of the proposed research is to test whether varenicline (Chantix) is safe and effective as an over-the-counter (OTC) medication.
Timeline
- Start
- 2018-05-07
- Primary completion
- 2022-04-16
- Completion
- 2022-04-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varenicline | Small molecule | 0.5 mg | — |
| Subject | Varenicline | Small molecule | 1 mg | — |